CSPC Innovation Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 300765.SZ

CSPC Innovation Pharmaceutical Co., Ltd. Revenue Per Share for the year ending December 31, 2023: USD 0.30

CSPC Innovation Pharmaceutical Co., Ltd. Revenue Per Share is USD 0.30 for the year ending December 31, 2023, a -11.88% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.

CSPC Innovation Pharmaceutical Co., Ltd. Revenue Per Share for the year ending December 31, 2022 was USD 0.34, a 48.98% change year over year.
CSPC Innovation Pharmaceutical Co., Ltd. Revenue Per Share for the year ending December 31, 2021 was USD 0.23, a 11.66% change year over year.
CSPC Innovation Pharmaceutical Co., Ltd. Revenue Per Share for the year ending December 31, 2020 was USD 0.21, a 11.86% change year over year.
CSPC Innovation Pharmaceutical Co., Ltd. Revenue Per Share for the year ending December 31, 2019 was USD 0.18, a -24.83% change year over year.

Key data

Date	Revenue Per Share	Dividend Per Share	Free Cash Flow Per Share	Return on Assets (ROA)

Shenzhen Stock Exchange: 300765.SZ

CSPC Innovation Pharmaceutical Co., Ltd.

CEO	Mr. Feng Han
IPO Date	March 22, 2019
Location	China
Headquarters	No. 36, Fuqiang Western Road
Employees	1,887
Sector	Consumers Staples
Industries Non-Alcoholic Beverages Alcoholic Beverages Consumer Packaged Goods Drugstores & Retail Pharmacies Pharmaceuticals Soft Drinks & Sodas Tobacco

Description

CSPC Innovation Pharmaceutical Co., Ltd. manufactures and sells caffeine, and vitamin C health supplement and beverage products. The company is based in Shijiazhuang, China. CSPC Innovation Pharmaceutical Co., Ltd. is a subsidiary of CSPC Pharmaceutical Group Limited.

Key trends

Past 5 years